NCT02608827

Brief Summary

Hypertension is serious health problem in Brazil and affects almost 30%of adult population. It is known that there are pharmacologic and nonpharmacologic strategies for treating hypertension. Aerobic exercise and slow breathing are nonpharmacologic methods that reduce blood pressure in an isolated form, but its combinations has never been studied. The aim of this study is to evaluate the association of both strategies and also the mechanisms involved in blood pressure reduction using slow breathing, in stages 1 and 2 hypertensives.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at below P25 for not_applicable hypertension

Timeline
Completed

Started Jan 2011

Longer than P75 for not_applicable hypertension

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2013

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

October 7, 2015

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 20, 2015

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

October 27, 2016

Status Verified

October 1, 2016

Enrollment Period

2.2 years

First QC Date

October 7, 2015

Last Update Submit

October 25, 2016

Conditions

Keywords

Hypertension; slow breathing; sympathetic nerve activity

Outcome Measures

Primary Outcomes (1)

  • Blood pressure reduction

    The reduction in blood pressure in mmHg immediately after after a single session of the association of aerobic exercise and guided slow breathing and during 24 hours blood pressure monitoring (ABPM).

    A session (1 day), after the placebo period of 30 days.

Secondary Outcomes (1)

  • Autonomic regulation

    A session (1 day), after the placebo period of 30 days.

Study Arms (2)

Slow breathing group (GRL)

ACTIVE COMPARATOR

After randomization and have done aerobic exercise, patients allocated in this arm of the study, using the device-guided breathing - Slow breathing group (GRL), for 15 minutes during the experimental session.

Device: Resperate®-InterCure Ltda

Music group (GC)

PLACEBO COMPARATOR

After randomization and have done aerobic exercise, patients allocated in this study arm will hear slow music - Music group (GC), for 15 minutes during the experimental session.

Other: Music group (GC)

Interventions

The device-guided breathing - Resperate®-InterCure Ltda, uses sound to guide and therefore reduce the respiration rate in individuals.

Slow breathing group (GRL)

The patients in this arm will hear slow music - Music group (GC).

Music group (GC)

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Adults aged 18 to 60 years, of both sexes not obese (BMI \<30 kg / m2);
  • Sedentary not to perform physical exercise for at least three months;
  • Hypertensive without target organ damage or untreated stage I and stage II (SBP 140-179 mmHg and DBP 90-109 mmHg) after four weeks with the use of placebo and without comorbidities; What would agree to participate in the study by signing the Instrument of Consent;

You may not qualify if:

  • Patients who presented blood pressure greater than 180/100 mmHg at any rate during the home monitoring of blood pressure and they needed treatment with active drug;
  • White-coat hypertension, or persistently elevated BP measurements (≥ 140/90 mmHg) in the office and BP means be considered normal in HBPM or ABPM.
  • Masked Hypertension, or high blood pressure office \<140/90 mmHg, and 24-hour ABPM with daytime BP\> 130/85 mmHg;
  • Patients with a history of alcoholism, drug abuse or mental disorders that could invalidate the consent, or limit the patient's ability to comply with the rules of the Protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

HypertensionHypoventilation

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesRespiratory InsufficiencyRespiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Post graduate

Study Record Dates

First Submitted

October 7, 2015

First Posted

November 20, 2015

Study Start

January 1, 2011

Primary Completion

March 1, 2013

Study Completion

December 1, 2015

Last Updated

October 27, 2016

Record last verified: 2016-10